BioNTech SE (BNTX) EBITDA (2018 - 2026)
BioNTech SE (BNTX) recorded EBITDA of -$792.73 million in Q2 2026, compared with -$509.5 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) EBITDA (2018 - 2026) Analysis & Trends
On a TTM basis, BioNTech SE's EBITDA came in at -$1.54 billion as of Jun 30, 2026; for FY2025, it came in at -$1.19 billion.
- Across earlier years, EBITDA came in at -$1.09 billion in FY2024, $940.16 million in FY2023 (-92.8%), $13.02 billion in FY2022 (-25.9%) and $17.57 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly EBITDA since Q2 2024.
- Peak year-over-year performance for EBITDA in the last five years was growth of 165.5% in Q1 2022, against a decline of 94.9% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$651.17 million (Q1 2026), -$183.92 million (Q4 2025) and $90.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | -792.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -792.73 Mn |
| Mar 31, 2026 | -651.17 Mn |
| Dec 31, 2025 | -183.92 Mn |
| Sep 30, 2025 | 90.37 Mn |
| Jun 30, 2025 | -509.50 Mn |
| Mar 31, 2025 | -516.79 Mn |
| Dec 31, 2024 | 335.54 Mn |
| Sep 30, 2024 | 60.29 Mn |
| Jun 30, 2024 | -986.75 Mn |
| Mar 31, 2024 | -509.40 Mn |
| Dec 31, 2023 | 650.94 Mn |
| Sep 30, 2023 | 124.53 Mn |
| Jun 30, 2023 | -578.65 Mn |
| Mar 31, 2023 | 736.10 Mn |
| Dec 31, 2022 | 3.39 Bn |
| Sep 30, 2022 | 2.44 Bn |
| Jun 30, 2022 | 2.39 Bn |
| Mar 31, 2022 | 5.37 Bn |
| Dec 31, 2021 | 5.41 Bn |
| Sep 30, 2021 | 5.63 Bn |
API Access
BioNTech SE EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();